当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:62.01亿  总市值:64.30亿
流通股本:3.70亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.47亿元,每股收益0.34元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益374277.10万元,未分配利润80990.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产594532.04万元,负债220254.94万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入2,568,752,667.571,705,293,296.69829,526,5423,505,716,962.18
营业总成本2,386,749,531.41,570,483,289.96765,199,920.753,133,449,189.56
营业利润175,516,338.76134,174,184.268,747,551.8353,777,276.11
利润总额176,301,377.39135,692,352.5570,236,722.17345,965,986.4
净利润146,655,023.18110,772,560.8554,879,668.97285,874,231.66
其他综合收益7,056,674.17,056,674.15,511,232.38-
综合收益总额153,711,697.28117,829,234.9560,390,901.35285,874,231.66
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,417,085,595.082,295,705,478.952,341,669,250.862,308,149,145.99
非流动资产合计3,528,234,800.043,541,542,485.363,545,550,099.543,517,934,444.98
资产总计5,945,320,395.125,837,247,964.315,887,219,350.45,826,083,590.97
流动负债合计1,608,234,932.211,612,252,564.041,620,823,694.481,700,938,461.45
非流动负债合计594,314,425.85492,953,583.33538,413,505.4465,833,072.45
负债合计2,202,549,358.062,105,206,147.372,159,237,199.882,166,771,533.9
归属于母公司股东权益合计3,680,271,565.753,674,083,382.613,671,272,645.93,607,438,065.73
股东权益合计3,742,771,037.063,732,041,816.943,727,982,150.523,659,312,057.07
负债和股东权益合计5,945,320,395.125,837,247,964.315,887,219,350.45,826,083,590.97
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计2,407,494,163.591,629,474,458.67772,155,286.992,838,249,790.35
经营活动现金流出小计1,946,573,132.531,348,090,746.37745,451,949.72,582,623,260.98
经营活动产生的现金流量净额460,921,031.06281,383,712.326,703,337.29255,626,529.37
投资活动现金流入小计190,021,568.5681,089,169.2646,924,883.6136,683,629.63
投资活动现金流出小计347,388,185.51210,416,118.21120,193,880.29394,507,166.03
投资活动产生的现金流量净额-157,366,616.95-129,326,948.95-73,268,996.68-357,823,536.4
筹资活动现金流入小计328,562,071.6216,662,071.6199,568,175.8532,908,869.31
筹资活动现金流出小计421,901,047.08309,430,906.41116,583,752.73529,079,450.11
筹资活动产生的现金流量净额-93,338,975.48-92,768,834.8182,984,423.073,829,419.2
汇率变动对现金及现金等价物的影响2,502,903.951,341,941.84-782,795.384,299,669.62
现金及现金等价物净增加额212,718,342.5860,629,870.3835,635,968.3-94,067,918.21
期末现金及现金等价物余额1,002,497,766.99850,409,294.79825,415,392.71789,779,424.41
TOP↑